174 related articles for article (PubMed ID: 38407745)
1. Dexmedetomidine alleviates Hypoxia/reoxygenation-induced mitochondrial dysfunction in cardiomyocytes via activation of Sirt3/Prdx3 pathway.
Tan Q; Dong W; Wang Q; Gao L
Daru; 2024 Jun; 32(1):189-196. PubMed ID: 38407745
[TBL] [Abstract][Full Text] [Related]
2. SIRT3-mediated deacetylation of PRDX3 alleviates mitochondrial oxidative damage and apoptosis induced by intestinal ischemia/reperfusion injury.
Wang Z; Sun R; Wang G; Chen Z; Li Y; Zhao Y; Liu D; Zhao H; Zhang F; Yao J; Tian X
Redox Biol; 2020 Jan; 28():101343. PubMed ID: 31655428
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine Ameliorates Cardiac Ischemia/Reperfusion Injury by Enhancing Autophagy Through Activation of the AMPK/SIRT3 Pathway.
He H; Liu P; Li P
Drug Des Devel Ther; 2023; 17():3205-3218. PubMed ID: 37908314
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine attenuates ischemia and reperfusion-induced cardiomyocyte injury through p53 and forkhead box O3a (FOXO3a)/p53-upregulated modulator of apoptosis (PUMA) signaling signaling.
Yang FY; Zhang L; Zheng Y; Dong H
Bioengineered; 2022 Jan; 13(1):1377-1387. PubMed ID: 34974801
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine Attenuates Cellular Injury and Apoptosis in H9c2 Cardiomyocytes by Regulating p-38MAPK and Endoplasmic Reticulum Stress.
Zhu Z; Ling X; Zhou H; Zhang C; Yan W
Drug Des Devel Ther; 2020; 14():4231-4243. PubMed ID: 33116411
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine reversed hypoxia/reoxygenation injury-induced oxidative stress and endoplasmic reticulum stress-dependent apoptosis of cardiomyocytes via SIRT1/CHOP signaling pathway.
Zhang Y; Zhao Q; Li X; Ji F
Mol Cell Biochem; 2021 Jul; 476(7):2803-2812. PubMed ID: 33725228
[TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine abates myocardial ischemia reperfusion injury through inhibition of pyroptosis via regulation of miR-665/MEF2D/Nrf2 axis.
Wang L; Liu J; Wang Z; Qian X; Zhao Y; Wang Q; Dai N; Xie Y; Zeng W; Yang W; Bai X; Yang Y; Qian J
Biomed Pharmacother; 2023 Sep; 165():115255. PubMed ID: 37549462
[TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine Ameliorates Hippocampus Injury and Cognitive Dysfunction Induced by Hepatic Ischemia/Reperfusion by Activating SIRT3-Mediated Mitophagy and Inhibiting Activation of the NLRP3 Inflammasome in Young Rats.
Yu W; Lyu J; Jia L; Sheng M; Yu H; Du H
Oxid Med Cell Longev; 2020; 2020():7385458. PubMed ID: 34493950
[TBL] [Abstract][Full Text] [Related]
9. Sappanone A alleviates hypoxia/reoxygenation-induced cardiomyocytes injury through inhibition of mitochondrial apoptosis and activation of PI3K-Akt-Gsk-3β pathway.
Shi X; Tao G; Ji L; Tian G
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32095825
[TBL] [Abstract][Full Text] [Related]
10. Involvement of GPR30 in protection effect of Dexmedetomidine against myocardial ischemia/reperfusion injury in rat via AKT pathway.
Shao Z; Shen Q; Kong M; Ni H; Hou X
Acta Biochim Pol; 2021 Feb; 68(1):119-126. PubMed ID: 33629579
[TBL] [Abstract][Full Text] [Related]
11. Glycine Protects H9C2 Cardiomyocytes from High Glucose- and Hypoxia/Reoxygenation-Induced Injury via Inhibiting PKC
Zhang Y; Su W; Zhang Q; Xu J; Liu H; Luo J; Zhan L; Xia Z; Lei S
J Diabetes Res; 2018; 2018():9502895. PubMed ID: 29850613
[TBL] [Abstract][Full Text] [Related]
12. Muscone alleviates myocardial ischemia-reperfusion injury via inhibition of oxidative stress and enhancement of SIRT3.
Wei CJ; Hua F; Chen YH; Zhang ZW; Shen ZY
J Biol Regul Homeost Agents; 2021; 35(1):85-96. PubMed ID: 33480219
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol Reestablishes Mitochondrial Quality Control in Myocardial Ischemia/Reperfusion Injury through Sirt1/Sirt3-Mfn2-Parkin-PGC-1α Pathway.
Zheng M; Bai Y; Sun X; Fu R; Liu L; Liu M; Li Z; Huang X
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080311
[TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine protects H9C2 against hypoxia/reoxygenation injury through miR-208b-3p/Med13/Wnt signaling pathway axis.
Wang Z; Yang Y; Xiong W; Zhou R; Song N; Liu L; Qian J
Biomed Pharmacother; 2020 May; 125():110001. PubMed ID: 32070878
[TBL] [Abstract][Full Text] [Related]
15. Clematichinenoside (AR) Attenuates Hypoxia/Reoxygenation-Induced H9c2 Cardiomyocyte Apoptosis via a Mitochondria-Mediated Signaling Pathway.
Ding H; Han R; Chen X; Fang W; Liu M; Wang X; Wei Q; Kodithuwakku ND; Li Y
Molecules; 2016 May; 21(6):. PubMed ID: 27248986
[TBL] [Abstract][Full Text] [Related]
16. Nicotinamide riboside attenuates myocardial ischemia-reperfusion injury via regulating SIRT3/SOD2 signaling pathway.
Zhao K; Tang J; Xie H; Liu L; Qin Q; Sun B; Qin ZH; Sheng R; Zhu J
Biomed Pharmacother; 2024 Jun; 175():116689. PubMed ID: 38703508
[TBL] [Abstract][Full Text] [Related]
17. Aqueous extract of Cortex Dictamni protects H9c2 cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress and apoptosis by PI3K/Akt signaling pathway.
Li L; Zhou Y; Li Y; Wang L; Sun L; Zhou L; Arai H; Qi Y; Xu Y
Biomed Pharmacother; 2017 May; 89():233-244. PubMed ID: 28231545
[TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine protects cardiomyocytes against hypoxia/reoxygenation injury via multiple mechanisms.
Cai S; Liu Y; Cheng Y; Yuan J; Fang J
J Clin Lab Anal; 2022 Jul; 36(7):e24119. PubMed ID: 34882841
[TBL] [Abstract][Full Text] [Related]
19. Sitagliptin mitigates hypoxia/reoxygenation (H/R)-induced injury in cardiomyocytes by mediating sirtuin 3 (SIRT3) and autophagy.
Yang M; Xi N; Gao M; Yu Y
Bioengineered; 2022 May; 13(5):13162-13173. PubMed ID: 35635037
[TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine Protects Cardiomyocytes against Hypoxia/Reoxygenation Injury by Suppressing TLR4-MyD88-NF-
Gao JM; Meng XW; Zhang J; Chen WR; Xia F; Peng K; Ji FH
Biomed Res Int; 2017; 2017():1674613. PubMed ID: 29359143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
